Technical Analysis for PACB - Pacific Biosciences of California, Inc.

Grade Last Price % Change Price Change
grade C 6.8 -1.59% -0.11
PACB closed down 1.59 percent on Friday, May 24, 2019, on 1.66 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical PACB trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup -9.57%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -9.57%
Bollinger Band Squeeze Range Contraction -9.57%
Narrow Range Bar Range Contraction -9.57%
Fell Below 20 DMA Bearish -9.69%
1,2,3 Pullback Bullish Bullish Swing Setup -9.69%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -9.69%
Bollinger Band Squeeze Range Contraction -9.69%
20 DMA Support Bullish -11.69%
Hammer Candlestick Bullish -11.69%

Older signals for PACB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a single molecule, real-time, (SMRT) technology for the detection of biological processes. Its SMRT technology enables to study the synthesis, composition, structure, and regulation of DNA, as well as to record individual biochemical events as they occur. It primarily focuses on the deoxyribonucleic acid sequencing market. The company's product includes the PacBio RS high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. Its PacBio RS high resolution genetic analyzer consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits to prepare and sequence DNA samples. The company's customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. markets its products through a direct sales force in North America and Europe, as well as through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Biotechnology Life Sciences Biology Molecular Biology Agilent Technologies Genomics Real Time Bioinformatics Dna Sequencing
Is PACB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 7.84
52 Week Low 2.48
Average Volume 1,469,590
200-Day Moving Average 6.4893
50-Day Moving Average 7.2988
20-Day Moving Average 7.2625
10-Day Moving Average 7.146
Average True Range 0.1191
ADX 28.44
+DI 6.5199
-DI 40.607
Chandelier Exit (Long, 3 ATRs ) 7.1427
Chandelier Exit (Short, 3 ATRs ) 7.0373
Upper Bollinger Band 7.647
Lower Bollinger Band 6.878
Percent B (%b) -0.1
BandWidth 10.58864
MACD Line -0.1079
MACD Signal Line -0.0463
MACD Histogram -0.0616
Fundamentals Value
Market Cap 786.02 Million
Num Shares 116 Million
EPS -0.92
Price-to-Earnings (P/E) Ratio -7.39
Price-to-Sales 5.01
Price-to-Book 4.14
PEG Ratio -0.16
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.17
Resistance 3 (R3) 7.17 7.05 7.11
Resistance 2 (R2) 7.05 6.95 7.05 7.09
Resistance 1 (R1) 6.92 6.90 6.86 6.92 7.07
Pivot Point 6.80 6.80 6.77 6.80 6.80
Support 1 (S1) 6.68 6.71 6.62 6.68 6.53
Support 2 (S2) 6.56 6.65 6.56 6.51
Support 3 (S3) 6.43 6.56 6.49
Support 4 (S4) 6.43